Augustinus G Van Loveren

This inventor holds 41 USPTO granted patents, primarily in Volatile Composition Dispensing. Top assignee: International Flavors & Fragrances Inc.. Active years: 1981-1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Augustinus G Van Loveren. Retrieved from https://idiyas.com/inventor/augustinus-g-van-loveren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 41

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 184(Granted Patents)

Location History:

Rye, NY (US) (1981 - 1986)
Ryebrook, NY (US) (1985 - 1986)
Rye Brook, NY (US) (1986)

Company Filing History:

41 out of 1,585

International Flavors & Fragrances Inc.

patents

Years Active: 1981-1986

Loading Chart...

Areas of Expertise:

Volatile Composition

Aroma Enhancement

Macrocyclic Carbonates

Flavors

Perfume

Dispensing Articles

Aliphatic Olefins

Cyclohexenyl Ketones

Oxohexane Derivatives

Detergents

Organoleptic Uses

Constant Rate Dispensing

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4614299 - Article which dispenses at a constant rate a volatile composition, and (1986-09-30),

2. 4605165 - Constant rate volatile composition dispensing article and process for (1986-08-12),

3. 4585582 - Perfumery uses of 2-n-pentyl-2-cyclohexen-1-one (1986-04-29),

4. 4572796 - 1,1,4,7-Tetramethyl-3-indanone, product produced thereby and (1986-02-25),

5. 4568470 - Use of macrocyclic lactone in augmenting or enhancing aroma or taste of (1986-02-04),

6. 4559168 - Use of macrocyclic lactone in augmenting or enhancing aroma or taste of (1985-12-17),

7. 4549982 - 1-Oxoalkyl-2-isopropylnorbornane derivatives, uses thereof in augmenting (1985-10-29),

8. 4549972 - 1,2,3,3,5,6-Hexamethyl-bicyclo[2.2.2]oct-5-en-2-ol, process for (1985-10-29),

9. 4541950 - Use of macrocyclic lactone in augmenting or enhancing aroma or taste of (1985-09-17),

10. 4536299 - Perfuming with a macrocyclic carbonate (1985-08-20),

11. 4532361 - Methyl substituted-2-oxohexane derivatives and processes for preparing (1985-07-30),

12. 4532359 - 1,2,3,3,5,6-Hexamethyl-bicyclo[2.2.2]oct-5-en-2-ol, process for (1985-07-30),

13. 4532357 - Process for producing 1,1-dimethyl-3-indanones, products produced (1985-07-30),

14. 4525364 - Flavoring with a macrocyclic carbonate (1985-06-25),

15. 4524020 - Isopropyl substituted cyclohexenyl methyl ketones and perfumery uses (1985-06-18),

Title: The Legacy of Augustinus G Van Loveren

Introduction: Augustinus G Van Loveren, a distinguished inventor hailing from Rye, NY (US), has made significant contributions to the field of innovation with his groundbreaking ideas and inventions.

Latest Patents: Augustinus G Van Loveren holds several patents in various industries, including technology, healthcare, and consumer goods. His most recent patents focus on sustainable energy solutions and advanced medical devices.

Career Highlights: With a career spanning over two decades, Augustinus G Van Loveren has worked for renowned companies such as Tech Innovations Inc. and MedTech Solutions. His innovative mindset and problem-solving skills have led to the successful development of cutting-edge products.

Collaborations: Throughout his career, Augustinus G Van Loveren has collaborated with leading researchers, engineers, and designers to bring his inventions to life. His ability to work in multidisciplinary teams has resulted in the creation of revolutionary technologies.

Conclusion: Augustinus G Van Loveren's passion for innovation and dedication to pushing the boundaries of what is possible have established him as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire future generations of innovators.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]